Why would Eli Lilly want to pick up rBGH?
Because they are partners in crime with Monsanto and the biotech industry–pushing largely untested and unlabeled genetically engineered products on an unwilling, but often gullible public. PRESS RELEASE CONTACT: (317) 277-7464 Joan Todd (Elanco) (317) 276-5795 – Mark Taylor (Lilly) Elanco Announces Acquisition of Posilac® Dairy Business Deal Provides Strategic Fit with Lilly’s Animal Health Division Greenfield, IN – Elanco, a division of Eli Lilly and Company (NYSE:LLY), today announced that Lilly has signed an agreement to acquire the worldwide rights to the dairy cow supplement, Posilac® (sometribove), as well as the product’s supporting operations, from Monsanto Company (NYSE:MON). “Global dairy demand is increasing, outstripping supply, and consumers are seeing rapidly rising prices,” said Jeff Simmons, president, Elanco. “With the purchase of Posilac, Elanco can enhance its overall product portfolio and work together with the industry to provide dairy farmers more options and g
